Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $256000.0.

  • LifeStance Health's Amortization of Deferred Charges fell 3904.76% to $256000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 3434.86%. This contributed to the annual value of $1.7 million for FY2024, which is 2070.44% down from last year.
  • Latest data reveals that LifeStance Health reported Amortization of Deferred Charges of $256000.0 as of Q3 2025, which was down 3904.76% from $255000.0 recorded in Q2 2025.
  • LifeStance Health's Amortization of Deferred Charges' 5-year high stood at $603000.0 during Q3 2022, with a 5-year trough of $251000.0 in Q1 2025.
  • For the 5-year period, LifeStance Health's Amortization of Deferred Charges averaged around $422352.9, with its median value being $420000.0 (2024).
  • In the last 5 years, LifeStance Health's Amortization of Deferred Charges surged by 10000.0% in 2022 and then tumbled by 4080.19% in 2025.
  • LifeStance Health's Amortization of Deferred Charges (Quarter) stood at $299000.0 in 2021, then surged by 100.0% to $598000.0 in 2022, then decreased by 14.88% to $509000.0 in 2023, then dropped by 21.02% to $402000.0 in 2024, then plummeted by 36.32% to $256000.0 in 2025.
  • Its Amortization of Deferred Charges was $256000.0 in Q3 2025, compared to $255000.0 in Q2 2025 and $251000.0 in Q1 2025.